Actelion to discuss its specialty immunology pipeline compounds Donnerstag, 16. April 2015 - 07:05

Dear member of the investment community

Actelion has announced that it is accelerating its clinical development efforts in the field of immunological disorders. An investor conference call & webcast will be held at 13.00 hrs, CEST to offer the opportunity to discuss the rational for this strategic decision.

Date/Time:

16 April 2015	13.00 hrs - 14.00 hrs	Basel (CEST)
	12.00 hrs - 13.00 hrs	UK (BST)
	07.00 a.m. - 08.00 a.m.	US (EDT)

 

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial:			Europe:		+41 (0) 44 580 00 77
			UK:		+44 (0) 203 367 94 59
			US:		+1 866 907 59 28

 

Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.

Webcast Access:

Webcast participants should visit the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start. 

Participant's mode:

Listen-Only           

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com/  approximately 60 minutes after the call has ended.